Bronchoscope Market Report 2026

Bronchoscope Market Overview

• Bronchoscope market size has reached to $3.2 billion in 2025 • Expected to grow to $5.58 billion in 2030 at a compound annual growth rate (CAGR) of 11.8% • Growth Driver: Increasing Respiratory Tract Disorders Drive Growth In The Bronchoscope Market • Market Trend: Innovations In The Bronchoscope Market For Minimally Invasive Lung Disease Diagnosis And Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the bronchoscope market include: • Flexible Bronchoscopes (Segmentation By By Type) → Expected gain of $1.5 Billion • Rigid Bronchoscopes (Segmentation By By Type) → Expected gain of $0.84 Billion

What Is Covered Under Bronchoscope Market?

A bronchoscope refers to a medical device that is used to visualize the inside of the lungs and airways. It is a flexible or rigid tube that has a camera and a light source at its tip, which allows a physician to see the walls of the trachea, bronchi, and bronchioles. Bronchoscopes are used for both diagnostic and therapeutic purposes, such as biopsy tissue, remove foreign objects, or perform various medical procedures in the airways. The main types of bronchoscopes are rigid bronchoscopes and flexible bronchoscopes. Rigid bronchoscopes are medical devices used for diagnostic and therapeutic purposes in the respiratory system. Rigid bronchoscopes are made of metal and consist of handles, tubes, and sheaths. It is used in diagnostic and therapeutic procedures such as foreign body removal, tumor removal, stent placement, biopsy, hemostasis, and laser therapy. The usability of bronchoscopes includes reusable bronchoscopes and disposable bronchoscopes that are applied in diagnosis and treatments. It is used in hospitals, clinics, ambulatory surgical centers, and others.

What Is The Bronchoscope Market Growth Forecast?

The bronchoscope market size is expected to see rapid growth in the next few years. It will grow to $5.58 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing adoption of disposable endoscopy solutions, rising focus on patient safety, expansion of interventional pulmonology procedures, growing investments in advanced endoscopy systems, increasing demand for workflow-efficient devices. Major trends in the forecast period include increasing adoption of single-use bronchoscopes, rising demand for video bronchoscopy systems, growing use of minimally invasive pulmonary procedures, expansion of advanced imaging and navigation features, enhanced focus on infection control.

What Is The Driver Of The Bronchoscope Market?

The rise in the prevalence of respiratory tract disorders is expected to propel the growth of the bronchoscope market going forward. Respiratory tract disorders are medical conditions that affect the respiratory system. It includes asthma, chronic obstructive pulmonary disease, pneumonia, bronchitis, cystic fibrosis, pulmonary fibrosis, and lung cancer. Bronchoscopy is a diagnostic and therapeutic tool that can be used to evaluate and treat a variety of respiratory tract disorders; thus, the rise in the prevalence of respiratory tract disorders leads to an increase in the bronchoscope market.For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Additionally, the incidence rate climbed from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Thus, the rise in the prevalence of respiratory tract disorders is expected to boost the bronchoscope industry.

How Will The Drivers Impact Growth In The Global Bronchoscope Market?

• Growing Burden Of Respiratory Diseases & Lung Cancer (Medium) – During the forecast period, the growing burden of respiratory diseases and lung cancer is expected to become a major growth driver for the bronchoscope market by 2030. The increasing prevalence of chronic obstructive pulmonary disease (COPD), asthma, pulmonary infections, and lung cancer is driving demand for advanced bronchoscopic diagnostic and therapeutic procedures. Healthcare providers are increasingly utilizing bronchoscopes for early-stage disease detection, tissue biopsy collection, airway examination, and minimally invasive interventions. Rising smoking rates, air pollution exposure, and aging populations are further contributing to the growing incidence of respiratory conditions worldwide. This expanding patient population is accelerating the adoption of advanced bronchoscopy systems across hospitals and specialty pulmonary centers. • Growing Hospital Investment In Bronchoscopy Suites (High) – During the forecast period, growing hospital investment in bronchoscopy suites is expected to emerge as a significant factor driving the expansion of the bronchoscope market by 2030. Hospitals and healthcare systems are increasing investments in specialized pulmonary care infrastructure to improve procedural efficiency, patient throughput, and respiratory disease management capabilities. The expansion of dedicated bronchoscopy suites equipped with advanced imaging platforms, robotic-assisted systems, and infection control technologies is strengthening procedural adoption across both developed and emerging healthcare markets. In addition, healthcare providers are focusing on upgrading endoscopy departments to support increasing patient volumes and improve clinical outcomes. • Technological Advances In Optics & Imaging (Low) – During the forecast period, the technological advances in optics and imaging are expected to act as a key growth catalyst for the bronchoscope market by 2030. Continuous innovation in high-definition visualization systems, narrow-band imaging, digital bronchoscopy, and robotic-assisted navigation technologies is improving diagnostic precision and procedural effectiveness. Advanced imaging capabilities enable physicians to detect smaller lesions, improve airway visualization, and perform more accurate minimally invasive interventions. Manufacturers are also focusing on portable and single-use bronchoscope technologies that enhance accessibility and reduce cross-contamination risks in clinical settings. As healthcare providers increasingly adopt technologically advanced bronchoscopy platforms, demand for next-generation systems is expected to rise steadily.

How Will The Restraints Impact Growth In The Global Bronchoscope Market?

• High Overhead Cost Of Bronchoscopy Procedure (Medium) – During the forecast period, the high cost associated with bronchoscopy procedures acts as a significant restraint for market growth. Expenses include advanced equipment, maintenance, sterilization, and skilled personnel, making the procedure costly for healthcare providers. This financial burden is particularly challenging for small hospitals and clinics with limited budgets. Additionally, patients in developing regions may find the procedure unaffordable, limiting adoption rates. Insurance coverage may not always fully compensate for these costs, further discouraging usage. Hospitals may hesitate to invest in expensive bronchoscopy systems due to uncertain return on investment. The cost barrier also restricts widespread implementation in rural and underserved areas. Overall, high overhead costs hinder market penetration and scalability. • Infection-Control Concerns With Reusable Scopes (High) – During the forecast period, the reusable bronchoscopes pose infection-control challenges, which act as a restraint for the market. Improper sterilization and reprocessing can lead to cross-contamination and hospital-acquired infections. This raises serious patient safety concerns and increases liability risks for healthcare providers. Strict regulatory guidelines for cleaning and disinfection add complexity and operational burden. Healthcare facilities must invest additional time and resources to ensure compliance with hygiene standards. Any lapse in protocol can damage the institution's reputation and lead to legal consequences. These concerns are pushing some providers toward single-use devices, but cost implications remain a challenge. As a result, infection risks limit the adoption of traditional reusable bronchoscopy systems. • Shortage Of Trained Interventional Pulmonologists (Low) – During the forecast period, the shortage of skilled interventional pulmonologists significantly restrains the growth of the bronchoscopy market. Bronchoscopy procedures require specialized training and expertise to ensure accuracy and patient safety. However, there is a limited pool of trained professionals, especially in developing regions. This shortage leads to longer waiting times and reduced procedural capacity in healthcare facilities. Training programs are time-intensive and require significant resources, slowing workforce expansion. Hospitals may be unable to fully utilize available equipment due to lack of expertise. This skill gap also affects the quality of procedures and patient outcomes. Consequently, the limited availability of trained professionals restricts market growth.

Key Players In The Global Bronchoscope Market

Major companies operating in the bronchoscope market are Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Karl Storz Endoscopy SE & Co. KG, Richard Wolf GmbH, Medtronic plc, Boston Scientific Corporation, Cook Medical LLC, Teleflex Incorporated, CONMED Corporation, Stryker Corporation, Verathon Inc., SonoScape Medical Corp., Shanghai AoHua Photoelectricity Endoscope Co. Ltd., EFER Endoscopy Srl, Novatech SA, Smiths Medical, Laborie Medical Technologies, Clarus Medical, Nihon Kohden Corporation

Global Bronchoscope Market Trends and Insights

Major companies operating in the bronchoscope market are focusing on developing advanced robotics with real-time imaging, to enhance diagnostic accuracy, reduce patient discomfort, and shorten recovery times during lung disease diagnosis and treatment. Advanced robotics with real-time imaging refers to robotic systems that use live imaging technologies to guide precise actions and decision-making in real time. For instance, in September 2024, TidalHealth Nanticoke, a US-based healthcare organization, launched an advanced robotic bronchoscopy system using the Ion platform to improve lung disease diagnosis and treatment. This state-of-the-art technology provides high-definition visualization and precision for less invasive lung tissue biopsies, enabling specialists to navigate complex bronchial passages more effectively.

What Are Latest Mergers And Acquisitions In The Bronchoscope Market?

In November 2023, Broncus Holding Corporation, a China-based medical device healthcare technology company, acquired a 100% stake in Hangzhou Jingliang Science and Technology Co., Ltd. for an undisclosed amount. With this acquisition, Broncus aims to bolster its technological capabilities by integrating Jingliang’s expertise in robotics and intelligent device manufacturing, thereby accelerating its development of flexible transbronchial surgical robots for interventional pulmonology. Hangzhou Jingliang Science and Technology Co. Ltd. is a China-based company that provides bronchoscopes and other medical devices.

What Defines the Bronchoscope Market?

The bronchoscope market consists of sales of fiber optic bronchoscopes and video bronchoscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bronchoscope Market Report 2026?

The bronchoscope market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bronchoscope industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.